Insiders who reported open-market trades in the last 12 months at the companies Steve Elms files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Adam S. Grossman - $1.41M in ADMA purchases and sales in the last 12 months
Jerrold B. Grossman - $251K in ADMA purchases and sales in the last 12 months
Steve Elms is a corporate insider of ADMA BIOLOGICS, INC. (ADMA). InsiderAlpha holds 8 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Steve Elms last file a Form 4?
The most recent primary Form 4 on record is dated 9 March 2026, one of 8 filings going back to 2024.
Has Steve Elms been buying or selling stock?
Recorded transactions: 3 open-market purchases ($253K) and 3 open-market sales ($8.83M) across all tracked filings.
Steve Elms files SEC Form 4 reports at ADMA BIOLOGICS, INC. (ADMA). 8 SEC Form 4 filings on record going back to 2024, most recently on 9 March 2026. Most recent open-market trade: bought $108K of ADMA on 9 March 2026. Lifetime open-market purchases: $253K. Lifetime open-market sales: $8.83M.
Recent transactions
18
The latest 18 SEC Form 4 transactions reported by Steve Elms.
InsiderAlpha's records for Steve Elms go back to 2024: 8 primary Form 4 filings, an average of 2.7 per year. The typical open-market purchase is $84K (3 buys totaling $253K). The largest single buy on record is $110K of ADMA in 2026. Sales side: 3 recorded sales totaling $8.83M, so the filing history runs sell-heavy by dollar value. No recorded transaction carries a Rule 10b5-1 plan flag. An absent flag does not establish whether a transaction was pre-arranged or discretionary.
